Eurand N.V.

Eurand N.V. is a pharmaceutical company that develops pharmaceutical and biopharmaceutical products. On February 11, 2011 Axcan completed the acquisition of Eurand N.V., a global specialty pharmaceutical company with operating units in the United States and Europe. The new company began its combined operations on February 14, 2011, and has announced its new name, Aptalis™, on May 4, 2011.